Pages that link to "Q108791564"
Jump to navigation
Jump to search
The following pages link to Gerd Ritter (Q108791564):
Displaying 50 items.
- Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains (Q24301525) (← links)
- The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily (Q24316074) (← links)
- Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations (Q24533572) (← links)
- Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses (Q24678759) (← links)
- Antibodies specifically targeting a locally misfolded region of tumor associated EGFR (Q27654155) (← links)
- A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer (Q28203323) (← links)
- Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles (Q28249760) (← links)
- Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer (Q28282730) (← links)
- Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2 (Q28298110) (← links)
- Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine (Q28483146) (← links)
- A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy (Q28709361) (← links)
- Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. (Q30739293) (← links)
- The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. (Q30864701) (← links)
- Identification of cancer/testis genes by database mining and mRNA expression analysis (Q31045922) (← links)
- Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. (Q31128265) (← links)
- Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma (Q33216729) (← links)
- Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer. (Q33347407) (← links)
- PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue (Q33407543) (← links)
- High-level expression of a phage display-derived scFv in Pichia pastoris (Q33474406) (← links)
- Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy (Q33522281) (← links)
- Seromic profiling of ovarian and pancreatic cancer (Q33739967) (← links)
- Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX. (Q33818995) (← links)
- High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma (Q33952837) (← links)
- Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors (Q33999909) (← links)
- T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. (Q34111757) (← links)
- Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8. (Q34111796) (← links)
- CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients (Q34154427) (← links)
- Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer (Q34210036) (← links)
- Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery (Q34310771) (← links)
- NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer (Q34325790) (← links)
- Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium. (Q34464025) (← links)
- A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor (Q34470390) (← links)
- Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine (Q34504625) (← links)
- NY-ESO-1: review of an immunogenic tumor antigen (Q34550142) (← links)
- CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit (Q34601772) (← links)
- Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination (Q34627677) (← links)
- In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. (Q34691545) (← links)
- Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer (Q34922631) (← links)
- Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. (Q35039508) (← links)
- Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab (Q35289145) (← links)
- Trypanosoma cruzi as an effective cancer antigen delivery vector. (Q35621200) (← links)
- A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors (Q35652789) (← links)
- Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase (Q35682009) (← links)
- Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. (Q35693584) (← links)
- Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. (Q35829136) (← links)
- Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients (Q35889432) (← links)
- Defining the critical hurdles in cancer immunotherapy (Q35916968) (← links)
- Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer (Q35921697) (← links)
- Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET. (Q35957293) (← links)
- (124)I-huA33 antibody PET of colorectal cancer. (Q36088144) (← links)